[Hebephrenic schizophrenia].
Umezu H.
Ryoikibetsu Shokogun Shirizu. 2003;(38):38-41.
[Hebephrenic schizophrenia].
Frikha A, Goldberger C.
Encephale. 2005 Oct;31 Pt 2:S27-9.
Hebephrenic schizophrenia.
Sister MARIE ELISE.
Can Nurse. 1960 Mar;56:248-50.
Hebephrenic schizophrenia.
Hoi HC.
Xianggang Hu Li Za Zhi. 1978 May;(24):21-6.
Heterogeneity of schizophrenia.
Tsuang MT.
Biol Psychiatry. 1975 Aug;10(4):465-74.
Paranoid vs hebephrenic schizophrenia: clinical and familial (genetic) heterogeneity.
Winokur G.
Psychopharmacol Commun. 1975;1(6):567-77.
CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia.
Ujike H, Takaki M, Nakata K, Tanaka Y, Takeda T, Kodama M, Fujiwara Y, Sakai A, Kuroda S.
Mol Psychiatry. 2002;7(5):515-8. doi: 10.1038/sj.mp.4001029.
Heterogeneity in schizophrenia: an extended replication of the hebephrenic-like and paranoid-like subtypes.
Williams J, Farmer AE, Wessely S, Castle DJ, McGuffin P.
Psychiatry Res. 1993 Dec;49(3):199-210. doi: 10.1016/0165-1781(93)90061-k.
Criteria for subtyping schizophrenia. Clinical differentiation of hebephrenic and paranoid schizophrenia.
Tsuang MT, Winokor G.
Arch Gen Psychiatry. 1974 Jul;31(1):43-7. doi: 10.1001/archpsyc.1974.01760130027004.
The micropsychopathology of hebephrenic/catatonic schizophrenia.
Pfohl B, Winokur G.
J Nerv Ment Dis. 1983 May;171(5):296-300. doi: 10.1097/00005053-198305000-00006.
